EP 0996623 A1 20000503 - 2,6-DI-t-BUTYL-4- (DIMETHYL-4-METHOXYPHENYLSILYL) -METHYLOXY PHENOL AND 2,6-DI-t-BUTYL-4- (DIMETHYL-2-METHOXY-PHENYLSILYL) -METHYLOXY PHENOL
Title (en)
2,6-DI-t-BUTYL-4- (DIMETHYL-4-METHOXYPHENYLSILYL) -METHYLOXY PHENOL AND 2,6-DI-t-BUTYL-4- (DIMETHYL-2-METHOXY-PHENYLSILYL) -METHYLOXY PHENOL
Title (de)
2,6-DI-T-BUTYL4-¬(DIMETHYL-4-METHOXYPHENYLSILYL)-METHYLOXY PHENOL UND 2,6-DI-T-BUTYL-4-¬(DIMETHYL-2-METHOXY-PHENYLSILYL)-METHYLOXY PHENOL
Title (fr)
2,6-DI-t-Butyl-4- (DIMETHYL-4-METHOXYPHENYLSILYL) -METHYL-OXY PHENOL ET 2,6-DI-t-BUTYL-4- (DIMETHYL-2-METHOXY-PHENYLSILYL) -METHYLOXY PHENOL
Publication
Application
Priority
- US 9810443 W 19980521
- US 88184397 A 19970625
Abstract (en)
[origin: WO9858937A1] This invention relates to the compounds of 2,6-di-t-butyl-4- [(dimethyl-4- methoxyphenylsilyl)-methyloxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxyphenylsilyl)methyloxy]phenol, polymorphs thereof and their pharmaceutically acceptable salts, useful as antiatherosclerotic agents.
IPC 1-7
IPC 8 full level
A61K 31/695 (2006.01); A61P 9/10 (2006.01); C07F 7/08 (2006.01)
CPC (source: EP)
A61P 9/10 (2017.12); C07F 7/0812 (2013.01)
Citation (search report)
See references of WO 9858937A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9858937 A1 19981230; AR 013115 A1 20001213; AU 7588498 A 19990104; CA 2295232 A1 19981230; EP 0996623 A1 20000503; JP 2002506443 A 20020226; ZA 985324 B 19990107
DOCDB simple family (application)
US 9810443 W 19980521; AR P980102978 A 19980622; AU 7588498 A 19980521; CA 2295232 A 19980521; EP 98923645 A 19980521; JP 50442699 A 19980521; ZA 985324 A 19980618